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Abstract 
Background: Despite some evidences about protective or triggering role of opium use in patients with coronary 
artery disease, the exact role of opium is still under question. The current study aimed to address the relation of 
opium dependence on the severity and extension of myocardial infarction (MI) and its related mortality. 
Methods: The study population consisted of 460 consecutive patients (239 opium addicts and 221 non-
addicts) with first acute MI. Study information was extracted from hospital recorded files as well as face to 
face interview. 
Findings: In-hospital mortality in opium addicted patients was numerically lower than another group  
(5.4% versus 8.2%), but this difference was not statistically significant. Regarding types of MI, anterior wall 
MI was higher in non-addicted patients than addicts (36.4% versus 26.4%). Among patients with anterior 
wall MI, early mortality was significantly higher in non-addicted compared to addicted subjects  
(20.0% versus 7.9% P = 0.043). The main associated factors of in-hospital mortality due to acute MI in 
addicts were advanced age and family history of coronary artery disease and in non-addicts were advanced 
age and hypertension. 
Conclusion: In current study total in-hospital mortality was not different between opium addicted and  
non-addicted groups but opium may reduce the occurrence of anterior wall MI and its related early mortality. 
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Introduction 
Although opium use is considered to have a 
declining trend in most societies, recent data have 
shown notable attendance to opium usage in 
some developing countries such as Iran.1-3 The 
incidence of opium addiction is especially higher 
in some diseases subgroups. The prevalence of 
opium addiction is about 2-2.8 percent among 
Iranian general population; whereas it was 
estimated about 9.9-19 percent in the group with 
acute myocardial infarction (MI).4,5 The most 
important reason for this high prevalence is the 
misconception in our population that opiates can 
prevent and control risk factors for coronary 
artery disease such as hypertension and diabetes 
mellitus and also has an ameliorating effect in the 
process of these factors.4 This belief about 
protective cardiovascular effects of opium has 
been extended even among a few physicians that 
some of them believe alternative treatment role of 
opium for some of cardiovascular risk factors 
specially diabetes.6,7  
However, this belief has not been supported 
by some recent basic and clinical investigations. In 
some of them, serum levels of biochemical risk 
factors for coronary artery disease such as 
lipoprotein (a) and C-reactive protein were 
significantly higher in opium addicted patients 
and these factors were major determinants of risk 
factor for premature atherosclerosis.8,9 Masoomi et 
al. reported that opium was an independent risk 
factor for coronary artery disease (CAD).10 
Furthermore, some basic trials have confirmed 
that opioid peptides are involved in ischemic 
preconditioning via K+-ATP channel in cardiac 
mitochondria that play a pivotal role in a number 
of pathological conditions in cardiovascular 
system.11,12 However, some other studies could 
find some evidences about protective role of 
opium use. Marmor et al. indicated that long-term 
exposure to opiates could be associated with 
decreased severity of coronary artery disease, and 
hence with decreased incidence of fatal MIs.13  
Furthermore, Najafi et al. revealed that the 
different domains of quality of life in opium-
addicted and non-addicted patients with coronary 
artery disease were not statistically different.14 
There is controversy among clinicians about the 
effects of opium on the cardiovascular system. In 
addition, these effects on outcome of different 
subgroups of acute MI have been unclear. The 
present study aimed to address the differences in 
clinical outcome of acute MI between opium 
addicted and non-addicted patients in different 
subgroups. Moreover, we determined the 
relationships between in-hospital mortality and 
opium dependence in different subgroups of MI. 
Finally, we tried to determine main predictors of 
short-term mortality in addicted and  
non-addicted patients with MI.  
Methods 
The study population consisted of 460 consecutive 
patients with first acute MI admitted within 6 
hours of the onset of chest pain to coronary care 
units (CCU) in the city of Kerman. Patients had 
the following criteria: 1) typical chest pain  
lasting ≥ 30 minutes; 2) ST-segment elevation ≥ 0.2 
mV in ≥ 2 contiguous precordial leads (for the 
diagnosis of anterior wall MI) or in leads V1–V3 
(for the diagnosis of anteroseptal wall MI) as well 
as ≥ 0.1 mV in II, III, and aVF leads (for the 
diagnosis of inferior wall MI) on the admission’s 
ECG; 3) increase in serum creatine kinase (CK) 
level more than twice the normal value; 4) no 
previous MI; 5) no other heart or lung disease.  
Participants were classified into two groups: 1) 
opium addicted patients (n = 239) and  
non-addicted patients (n = 221). Opium addiction 
was defined on the basis of the DSM-IV criteria 
for substance dependence as regularly 
consumption of inhalatory opium more than three 
times per week and/or oral opium daily.15 
Demographic characteristics and clinical criteria 
of these patients were extracted from hospital 
recorded files as well as face to face interview if 
required, and were entered into a computerized 
database form. The patients were given self-
administered questionnaires about their medical 
history and early complications after MI including 
general characteristics, Killip class and coronary 
artery disease risk factors: Current smoking 
history (patients regularly smoke a tobacco 
product/products one or more times per day or 
have smoked in the 30 days prior to admission),16 
hypercholesterolemia (total cholesterol ≥ 5.0 
mmol/l, HDL-cholesterol ≥ 1.0 mmol/l in men,  
or ≥ 1.1 mmol/l in women, and triglycerides ≥ 2.0 
mmol/l),17 family history of CAD (first-degree 
relatives before the age of 55 in men and 65 years 
in women),18 hypertension (systolic blood 
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pressure ≥ 140 mmHg and/or diastolic ≥ 90 
mmHg and/or on antihypertensive treatment),18 
diabetes mellitus (symptoms of diabetes plus at 
least one of the following: plasma glucose 
concentration ≥ 11.1 mmol/l, fasting plasma 
glucose ≥ 7.0 mmol/l, and 2-hpp ≥ 11.1 mmol/l).20 
We considered in-hospital MI as criteria for in-
hospital outcome.  
Results were reported as mean ± standard 
deviation (SD) for the quantitative variables and 
percentages for the categorical variables. The 
groups were compared using the Student's t-test 
for the continuous variables and the chi-square 
test (or Fisher's exact test if required) for the 
categorical variables. Predictors exhibiting a 
statistically significant relation with mortality in 
the two groups in univariate analyses were taken 
for multivariate logistic regression analysis to 
investigate their independence as predictors. 
Odds ratio (OR) and 95% confidence intervals (CI) 
were calculated. This study was done with the 
power of 90%. P-values of 0.05 or less were 
considered statistically significant. All the 
statistical analyses were performed using SPSS 
version 13.0 (SPSS Inc., Chicago, IL, USA) and 
SAS version 9.1 for Windows (SAS Institute Inc.,  
Cary, NC, USA). 
Results 
As presented in table 1, opium addicted and non-
addicted patients were similar in terms of Killip 
class, left ventricular ejection fraction as well as 
lipid profiles. However, male to female ratio was 
higher in opium addicted patients and these 
participants were younger than the non-addicted 
ones. Among general risk factors for coronary 
artery disease, only family history of heart disease 
was not different between the addicted and non-
addicted patients. The overall prevalence of 
hypertension and diabetes mellitus were higher in 
non-addicted participants, whereas history of 
current cigarette smoking was more in opium 
addicted individuals. There was no significant 
difference with respect to in-hospital mortality 
between too groups (P = 0.242).  
Regarding types of MI, anterior wall MI was 
found to be higher in non-addicted patients than 
addicts (36.4% versus 26.4%, P = 0.021); however, 
the incidence of inferior wall MI was similar in the 
two groups (43.0% versus 41.6%, P = 0.761). 
Among patients with anterior wall MI, early 
mortality was significantly higher in non- addicted 
 
Table 1. Baseline characteristics and clinical data of study patients 
Characteristics Total (n = 460) 
Opium addicted 
(n = 239) 
Non-addicted 
(n = 221) P 
Male gender 348 (75.8) 207 (86.6) 141 (64.1) < 0.001 
Age (year) 58.1 ± 12.0 55.5 ± 11.4 60.8 ± 12.1 < 0.001 
Current smoking 169 (39.9) 135 (64.0) 34 (16.0) < 0.001 
Diabetes mellitus 132 (28.8) 55 (23.1) 77 (35.0) 0.005 
Hypertension 143 (31.2) 64 (26.8) 79 (35.9) 0.033 
Family history of CAD 96 (20.9) 46 (19.2) 50 (22.7) 0.360 
Killip class     
I 314 (72.2) 169 (74.4) 145 (69.7)  
II 85 (19.5) 42 (18.5) 43 (20.7) 0.625 
III 23 (5.3) 11 (4.8) 12 (5.8)  
IV 13 (3.0) 5 (2.2) 8 (3.8)  
Ejection fraction (%) 44.0 ± 9.9 44.7 ± 9.4 43.2 ± 10.4 0.126 
Myocardial infarction:     
Anteroseptal wall 119 (25.9) 71 (29.7) 48 (21.8) 0.053 
Anterior wall 143 (31.2) 63 (26.4) 80 (36.4) 0.021 
Inferior wall 197 (42.9) 105 (43.9) 92 (41.8) 0.649 
Laboratory parameters:     
Fasting blood sugar 145.3 ± 71.0 136.2 ± 65.1 155.0 ± 75.8 0.007 
Triglyceride 148.8 ± 97.9 137.3 ± 80.9 160.9 ± 112.0 0.012 
Cholesterol 202.9 ± 54.4 198.8 ± 55.3 207.3 ± 53.2 0.104 
HDL 43.1 ± 12.2 43.3 ± 14.2 42.9 ± 9.8 0.848 
LDL 116.6 ± 52.0 116.5 ± 44.8 116.7 ± 58.8 0.979 
Data are presented as mean ± SD or n (%) 
CAD: Coronary artery disease HDL: High density lipoprotein LDL: Low density lipoprotein 
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compared to addicted subjects (20.0% versus 
7.9%). Regarding types of MI, anterior wall MI 
was more appeared in non-addicted patients and 
inferior MI was similar between the two groups. 
With regard to in-hospital mortality following 
acute MI (Table 2), among patients with anterior 
wall MI, the rate of mortality was significantly 
higher in non-addicted compared to addicted 
subjects (20.0% versus 7.9%, P = 0.043). However, 
in other types of MI, mortality rates were not 
different between the two study groups. Although 
in opium-addicted group, short-term mortality 
rates were comparable between the different 
types of MI, mortality was occurred more in those 
with anterior wall MI in non-addicted group.  
Multivariable regression analysis revealed that 
the main associated factors of in-hospital 
mortality due to acute MI in opium-addicted 
patients were advanced age [odds ratio (OR): 
1.121, P = 0.002] and family history of coronary 
artery disease (OR: 4.407, P = 0.040) (Table 3). In 
non-addicted patients, advanced age (OR: 1.076,  
P = 0.003) and hypertension (OR: 4.776, P = 0.004) 
could effectively predict short-term mortality 
following acute MI (Table 4).  
Discussion 
Current study tried to identify the role of opium 
dependence as a trigger for short-term mortality 
due to MI. Furthermore, relationship between the 
type of infarction and mortality in the two groups 
of patients who were addicted to opium and non-
addicted ones was determined. The prevalence of 
opium addiction in our study group was 
estimated as 52.0% that was considerably high. In 
a study by Ziaaddini et al.1 it was suggested that 
the prevalence of substance abuse in rural area in 
Kerman was 22.5% with addiction rate of 6%. 
Their study mainly focused on general 
population. However, regarding the prevalence of 
opium addiction among patients with coronary 
artery disease, some other studies on Iranian 
population confirmed significantly high 
prevalence of opium dependence in those with 
early onset coronary artery disease in comparison 
with normal subjects.21 It seems that cultural 
 
Table 2. In-hospital mortality following acute myocardial infarction in opium addicted and non-
addicted patients 
Type of myocardial infarction Total (n = 460) 
Opium addicted 
(n = 239) 
Non-addicted 
(n = 221) P 
Anteroseptal wall 2 (1.7) 2 (2.8) 0 (0) 0.515 
Anterior wall 21 (14.7) 5 (7.9) 16 (20.0) 0.043 
Inferior wall 9 (4.5) 6 (5.7) 3 (3.2) 0.284 
P < 0.001 0.421 < 0.001  
 
Table 3. Determinants of in-hospital mortality following acute myocardial infarction in opium addicted 
patients in the presence of cofounders 
Item Multivariable P Odds ratio 
95% Confidence intervals 
Lower limit Upper limit 
Female gender 0.335 0.521 0.138 1.961 
Advanced age 0.002 1.121 1.042 1.207 
Diabetes mellitus 0.165 0.418 0.122 1.433 
Family history of CAD 0.040 4.407 1.073 18.094 
Hypertension  0.541 1.487 0.416 5.316 
Hosmer- Lemeshow goodness of fit: χ2 = 13.949, P = 0.083 CAD: Coronary artery disease 
 
Table 4. Determinants of in-hospital mortality following acute myocardial infarction in non-addicted 
patients in the presence of cofounders 
Item Multivariable P Odds ratio 
95% Confidence intervals 
Lower limit Upper limit 
Female gender 0.106 2.671 0.810 8.800 
Advanced age 0.003 1.076 1.025 1.130 
Diabetes mellitus 0.135 0.435 0.146 1.297 
Family history of CAD 0.799 1.187 0.318 4.429 
Hypertension 0.004 4.776 1.664 13.874 
Hosmer- Lemeshow goodness of fit: χ2 = 8.730, P = 0.366 CAD: Coronary artery disease 
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factors and socioeconomic status are the most 
important reasons for high opium dependence 
among Kerman’s population. These effective 
factors have been identified on the basis of 
population-based studies so that the positive 
attitudes towards drug consumption and faulty 
knowledge of therapeutic use of opium were 
recognized as affecting factors on addiction 
tendency in Kerman.22  
Effect of opium use on the physiopathological 
processes of myocardial ischemia and infarction 
has been under question. Some studies showed 
that the opiates could be a potential risk factor for 
the severity of cardiac ischemia. In a study by 
Sadeghian et al.21 relationship between the 
presence of coronary artery disease and opium 
addiction was confirmed only in men especially in 
those with the history of current smoking. 
Furthermore, it has been indicated that the 
influence of opium addiction on progression of 
atherosclerosis might be restricted to presence of 
hypercholesterolemia. In fact, in 
normocholesterolemic animal models, opium 
could not change the atherogenic processes.3 
Moreover, some researches confirmed the 
deleterious effects of opium on traditional risk 
factors including hemoglobin A1c, high-density 
lipoprotein, lipoprotein (a), factor VII, fibrinogen 
and C-reactive protein. However, they also 
showed that these deleterious effects were 
dependant to the period of addiction and their 
levels were increased following long-term opium 
addiction.7 In addition, some other studies 
hypothesized the protective effects of opium on 
the severity and extension of coronary artery 
disease. Marmor et al.13 indicated a significant 
protective effect against adjusting for age and a 
history of hypertension.  
In the present study, non-addicted patients 
suffered from anterior wall MI more than addicts 
and opium use could affect the severity and 
extension of atherosclerosis by reducing the 
occurrence of anterior wall MI. One possible 
explanation for this finding is that narcotics may 
decrease inflammation, which is directly 
associated with atherogenesis and plaque 
disruption.23-26 Recent biological studies were also 
provided some evidences for a protective function  
of opioids via K-ATP channels in the heart.11,12 
Furthermore, stimulating some opioid receptor 
agonists such as TAN-67 reduces infarct size via 
activation of those channels.27-29 Moreover, 
Masoomi et al. showed that the response of 
addicts to the streptokinase was more prominent 
in comparison with non-addicts.30 Therefore, 
long-term use of opiates may be associated with 
decreased severity of CAD, hence, with a 
decreased incidence of fatal anterior wall MI. 
In current study, although total in-hospital 
mortality in opium addicted patients was 
numerically higher than another group  
(5.4% versus 8.2%), but this difference was not 
statistically significant. However, with regard to 
death following different types of MI, mortality 
rate in non-addicts was significantly higher in 
anterior wall group, whereas this rate was similar 
in the types of MI among addicted ones. Similarly, 
in Davoodi et al. study,31 no significant difference 
was observed in specifications, short term 
outcome and prognosis of acute MI between 
opium dependents and non-dependents except 
for duration of hospitalization. We think that the 
dependence to opiates not only may reduce the 
incidence of anterior wall infarction, but also 
decrease the mortality caused by this type of 
infarction in opium users. However, we strongly 
emphasize that the direct use of opiates should 
not be programmed for improving outcome of MI 
because of their other harmful physical, 
psychological and social effects. Therefore, the use 
of these compounds should be limited to the 
administration of opioid drugs in high risk 
groups especially under consideration of 
specialists.  
Conclusion 
In current study, total in-hospital mortality was 
not significantly different between opium 
addicted and non-addicted groups but opium 
may reduce the appearance of anterior wall MI 
and its related early mortality. However, in 
administration of drugs originated from opiates, 
their harmful side effects should be considered.  
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